Skip to main content

Displaying 1 - 20 of 42

Hackensack Meridian Health, Inc. and Englewood Healthcare Foundation

The Federal Trade Commission filed an administrative complaint and authorized a suit in federal court, to block Hackensack Meridian Health, Inc.’s proposed acquisition of Englewood Healthcare Foundation. The complaint alleges that the merged healthcare system would control three of the six inpatient general acute care hospitals in Bergen County, New Jersey. The proposed acquisition would eliminate close competition between Hackensack Meridian Health and Englewood in Bergen County and leave insurers with few alternatives for inpatient general acute care services, which encompass a broad range of inpatient medical and surgical diagnostic and treatment services that require an overnight hospital stay. The administrative trial will begin 30 days after the Third Circuit Court of Appeals rules on the appeal of the Preliminary Injunction.

Type of Action
Federal
Last Updated
FTC Matter/File Number
2010044
Case Status
Pending

Environmental Safety International, Inc.

In July 2021, the owners of a New Jersey-based company that sells septic tank cleaning products agreed to a permanent ban on telemarketing and will pay more than $1.6 million to settle FTC charges that the company and its telemarketer made illegal robocalls to consumers, including tens of millions of calls to numbers listed on the agency’s DNC Registry. In addition, the defendants will turn over a residential property as part of the settlement. The complaint names as defendants: Environmental Safety International, Inc. or ESI; ESI’s two officers, brothers Joseph Carney and Sean Carney; and their other brother Raymond Carney.

Type of Action
Federal
Last Updated
FTC Matter/File Number
182 3201
Case Status
Pending

Gerber Products Co., doing business as Nestlé Nutrition, et al.

In October 2014, the FTC charged Gerber Products Co. with deceptively advertising that feeding its Good Start Gentle formula to infants with a family history of allergies prevents or reduces the risk that they will develop allergies. The FTC also alleged that Gerber falsely advertised Good Start Gentle’s health claims as FDA-approved. The stipulated court order announced today, which the court has entered as final, settles the FTC’s charges and prohibits Gerber from similar conduct in the future.

Type of Action
Federal
Last Updated
FTC Matter/File Number
132 3009
X150016